From FGFR2 mutations to precision management: a review of prenatal diagnosis and multidisciplinary interventions in apert syndrome

从FGFR2突变到精准管理:APERT综合征的产前诊断和多学科干预综述

阅读:1

Abstract

Apert syndrome is a severe autosomal dominant disorder caused by recurrent FGFR2 mutations, characterized by the prenatal triad of craniosynostosis, midface hypoplasia, and symmetric syndactyly. This review synthesizes evidence defining core sonographic features: turribrachycephaly secondary to bicoronal suture fusion, facial profile abnormalities including depressed nasal bridge and hypertelorism, and the distinctive "mitten hands/sock feet" syndactyly pattern best visualized via advanced 3D ultrasound in late gestation. Fetal MRI complements ultrasound by identifying associated intracranial anomalies and microstructural brain changes linked to neurodevelopmental outcomes. A definitive diagnosis relies on targeted FGFR2 sequencing. Prenatal identification of these features enables essential coordinated care, including thorough parental counseling, proactive perinatal planning for potential airway compromise, and coordinated neonatal care involving craniofacial, genetic, and neurodevelopmental specialists. The integration of structured imaging assessment with rapid molecular diagnostics facilitates a shift from passive anomaly identification to proactive, risk-stratified management, thereby optimizing the long-term functional prognosis through timely interventions.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。